Daniel J Buckley, MD
Ophthalmology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 2
- Since medical school
- 43 years
- Tulane University School of Medicine, 1983
Offices
2 locations · Farallon Eye Physicians Corp · County of San Mateo
Looking this up.
Hospitals listed: Ahmc Seton Medical Center · San Mateo Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Buckley’s office at (650) 992-9223 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G62652 · Current
Licensed to practise in California · since 1988 · expires 2028-02-29 · Tulane University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- NBASC LLC dba North Bay Ambulatory Surgery CenterAmbulatory Surgery Center · Daly City, CA1% owner since 2024 · accredited by HFAPInitial Accreditation1 inspection, 1 with deficiencies · last 2025-06-12: Requirements Met
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$116,859
Medicare paid this office $116,859 for 398 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 36 | $28,721 | $513 |
| Established patient complete exam of visual system | 169 | $17,274 | $98 |
| Photography of the retina | 295 | $10,251 | $32 |
| Return visit (30+ min) | 84 | $9,743 | $116 |
| Established patient problem focused exam of visual system | 90 | $9,103 | $75 |
See all 13 services
| Removal of cataract with insertion of prosthetic lens | 36 | $28,721 | $513 |
| Established patient complete exam of visual system | 169 | $17,274 | $98 |
| Photography of the retina | 295 | $10,251 | $32 |
| Return visit (30+ min) | 84 | $9,743 | $116 |
| Established patient problem focused exam of visual system | 90 | $9,103 | $75 |
| Imaging of retina | 166 | $6,453 | $36 |
| New patient complete exam of visual system | 54 | $5,587 | $103 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $4,593 | $306 |
| Short return visit (20+ min) | 49 | $4,423 | $85 |
| Exam of visual field with extended testing | 53 | $4,189 | $63 |
| New patient visit (45+ min) | 19 | $2,512 | $132 |
| Imaging of optic nerve | 67 | $2,509 | $31 |
| Ultrasound scan to determine eye length and lens power | 16 | $1,156 | $34 |
Procedures Medicare counted
| Cataract surgery | 72 | More than 70% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 88 | 47 | 48 | 43 | 49 | 56 |
| Removal of recurring cataract in lens capsule using a laser | 30 | 22 | 35 | 20 | – | 15 |
| Complex removal of cataract with insertion of prosthetic lens | 26 | – | 12 | 15 | 17 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
398 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 15% · Women 60% · Also on Medicaid 36% · Health risk score 1.24. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 46% · Chronic kidney disease 29% · Coronary heart disease 23% · Heart failure 16% · Atrial fibrillation 14% · Cancer 11% · Depression 11% · COPD 10% · Dementia 7% · Stroke 7%.
The office billed $347,799, Medicare allowed $163,160 and paid $116,859; for 1,290 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 398 | 1,290 | 75 | 1.24 | $347,799 | $116,859 |
| 2023 | 376 | 1,210 | 76 | 1.31 | $333,808 | $111,807 |
| 2022 | 406 | 1,056 | 76 | 1.21 | $305,188 | $111,218 |
| 2021 | 412 | 948 | 75 | 1.23 | $258,939 | $118,981 |
| 2020 | 433 | 922 | 75 | 1.41 | $229,090 | $113,128 |
| 2019 | 573 | 1,282 | 76 | 1.36 | $416,556 | $189,128 |
| 2018 | 554 | 1,292 | 76 | 1.19 | $400,336 | $188,909 |
| 2017 | 656 | 1,547 | 75 | 1.27 | $477,557 | $219,162 |
| 2016 | 660 | 1,526 | 76 | 1.24 | $425,557 | $203,546 |
| 2015 | 648 | 1,451 | 76 | 1.15 | $399,780 | $203,661 |
| 2014 | 682 | 1,413 | 76 | 1.19 | $402,633 | $199,136 |
| 2013 | 746 | 1,756 | 76 | 1.17 | $591,003 | $230,371 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Established patient complete exam of visual system | 238 | $26,356 | $106 |
| Removal of cataract with insertion of prosthetic lens | 34 | $24,793 | $506 |
| Established patient problem focused exam of visual system | 110 | $13,105 | $75 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $11,233 | $661 |
| Photography of the retina | 269 | $9,409 | $33 |
| Imaging of retina | 131 | $5,193 | $37 |
| New patient complete exam of visual system | 45 | $4,794 | $107 |
| Exam of visual field with extended testing | 60 | $4,047 | $57 |
| Imaging of optic nerve | 67 | $2,633 | $32 |
| Ultrasound scan to determine eye length and lens power | 17 | $1,196 | $34 |
| Return visit (30+ min) | 11 | $1,184 | $108 |
2022: 16 services
| Established patient complete exam of visual system | 210 | $23,420 | $107 |
| Removal of cataract with insertion of prosthetic lens | 31 | $21,113 | $491 |
| Established patient problem focused exam of visual system | 137 | $16,283 | $75 |
| Complex removal of cataract with insertion of prosthetic lens | 13 | $10,463 | $698 |
| New patient complete exam of visual system | 49 | $6,167 | $126 |
| Removal of recurring cataract in lens capsule using a laser | 15 | $6,027 | $301 |
| Photography of the retina | 152 | $5,277 | $34 |
| Return visit (30+ min) | 41 | $4,147 | $94 |
| Exam of visual field with extended testing | 51 | $2,909 | $54 |
| Imaging of retina | 64 | $2,625 | $39 |
| Imaging of optic nerve | 55 | $1,835 | $31 |
| New patient visit (45+ min) | 13 | $1,631 | $125 |
| Short return visit (20+ min) | 15 | $1,173 | $73 |
| Ultrasound scan to determine eye length and lens power | 13 | $964 | $34 |
| Measurement of corneal curvature and depth of eye | 11 | $428 | $31 |
| Ultrasound scan of cornea to determine thickness | 12 | $127 | $11 |
2021: 14 services
| Removal of cataract with insertion of prosthetic lens | 34 | $24,385 | $508 |
| Established patient complete exam of visual system | 214 | $22,341 | $103 |
| Established patient problem focused exam of visual system | 151 | $20,527 | $83 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $10,486 | $300 |
| Complex removal of cataract with insertion of prosthetic lens | 12 | $8,351 | $696 |
| New patient complete exam of visual system | 49 | $6,173 | $126 |
| Return visit (30+ min) | 46 | $5,607 | $100 |
| New patient visit (45+ min) | 26 | $3,803 | $146 |
| Exam of visual field with extended testing | 61 | $3,346 | $52 |
| Long return visit (40+ min) | 26 | $3,124 | $120 |
| Imaging of optic nerve | 62 | $1,881 | $30 |
| Measurement of corneal curvature and depth of eye | 31 | $1,751 | $40 |
| Short return visit (20+ min) | 15 | $1,479 | $82 |
| Ultrasound scan of cornea to determine thickness | 12 | $134 | $11 |
2020: 13 services
| Removal of cataract with insertion of prosthetic lens | 33 | $24,358 | $518 |
| Established patient complete exam of visual system | 158 | $16,617 | $105 |
| Long return visit (40+ min) | 103 | $12,854 | $122 |
| Return visit (30+ min) | 110 | $12,532 | $91 |
| Established patient problem focused exam of visual system | 91 | $10,033 | $79 |
| Removal of recurring cataract in lens capsule using a laser | 17 | $6,778 | $308 |
| New patient visit (45+ min) | 43 | $6,108 | $142 |
| New patient complete exam of visual system | 34 | $4,119 | $121 |
| Exam of visual field with extended testing | 54 | $3,017 | $55 |
| Measurement of corneal curvature and depth of eye | 33 | $2,484 | $52 |
| Imaging of optic nerve | 55 | $1,640 | $30 |
| Short return visit (20+ min) | 20 | $1,270 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,037 | $65 |
2019: 14 services
| Removal of cataract with insertion of prosthetic lens | 65 | $53,252 | $605 |
| Return visit (30+ min) | 173 | $22,522 | $95 |
| Established patient complete exam of visual system | 188 | $19,625 | $104 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $19,464 | $749 |
| Long return visit (40+ min) | 125 | $15,128 | $120 |
| Established patient problem focused exam of visual system | 120 | $11,563 | $78 |
| Removal of recurring cataract in lens capsule using a laser | 24 | $8,987 | $300 |
| New patient visit (45+ min) | 64 | $8,642 | $135 |
| New patient complete exam of visual system | 42 | $5,511 | $131 |
| Exam of visual field with extended testing | 86 | $4,784 | $55 |
| Measurement of corneal curvature and depth of eye | 54 | $4,461 | $54 |
| Imaging of optic nerve | 70 | $2,394 | $33 |
| Short return visit (20+ min) | 18 | $1,244 | $59 |
| Ultrasound scan of cornea to determine thickness | 11 | $110 | $10 |
2018: 14 services
| Removal of cataract with insertion of prosthetic lens | 66 | $59,583 | $627 |
| Established patient complete exam of visual system | 216 | $25,022 | $115 |
| Return visit (30+ min) | 153 | $19,929 | $96 |
| Established patient problem focused exam of visual system | 118 | $12,938 | $86 |
| Long return visit (40+ min) | 93 | $11,549 | $124 |
| Complex removal of cataract with insertion of prosthetic lens | 12 | $10,627 | $759 |
| New patient complete exam of visual system | 54 | $6,762 | $125 |
| Measurement of corneal curvature and depth of eye | 55 | $5,589 | $61 |
| Removal of recurring cataract in lens capsule using a laser | 15 | $5,477 | $304 |
| Exam of visual field with extended testing | 91 | $5,466 | $60 |
| New patient visit (45+ min) | 32 | $4,326 | $135 |
| Imaging of optic nerve | 68 | $2,503 | $37 |
| Short return visit (20+ min) | 22 | $1,387 | $58 |
| Ultrasound scan of cornea to determine thickness | 52 | $765 | $15 |
2017: 15 services
| Removal of cataract with insertion of prosthetic lens | 77 | $62,643 | $585 |
| Established patient complete exam of visual system | 238 | $23,970 | $101 |
| Return visit (30+ min) | 172 | $20,239 | $96 |
| Established patient problem focused exam of visual system | 177 | $17,596 | $74 |
| Long return visit (40+ min) | 129 | $16,809 | $126 |
| Complex removal of cataract with insertion of prosthetic lens | 17 | $13,217 | $734 |
| Removal of recurring cataract in lens capsule using a laser | 31 | $12,392 | $295 |
| New patient visit (45+ min) | 79 | $10,403 | $132 |
| Exam of visual field with extended testing | 119 | $7,071 | $54 |
| Measurement of corneal curvature and depth of eye | 67 | $7,009 | $67 |
| New patient complete exam of visual system | 58 | $6,409 | $111 |
| Short return visit (20+ min) | 32 | $2,361 | $64 |
| New patient complete exam of visual system | 18 | $1,339 | $74 |
| Established patient complete exam of visual system | 11 | $555 | $50 |
| Ultrasound scan of cornea to determine thickness | 41 | $545 | $13 |
2016: 16 services
| Removal of cataract with insertion of prosthetic lens | 70 | $59,611 | $590 |
| Established patient complete exam of visual system | 359 | $35,543 | $98 |
| Established patient problem focused exam of visual system | 248 | $30,608 | $75 |
| Removal of recurring cataract in lens capsule using a laser | 31 | $11,028 | $298 |
| Complex removal of cataract with insertion of prosthetic lens | 13 | $9,325 | $717 |
| New patient complete exam of visual system | 68 | $8,481 | $125 |
| Return visit (30+ min) | 85 | $8,108 | $86 |
| Exam of visual field with extended testing | 105 | $6,014 | $57 |
| New patient visit (45+ min) | 35 | $4,297 | $123 |
| Ultrasound scan to determine eye length and lens power | 38 | $3,346 | $63 |
| Measurement of corneal curvature and depth of eye | 28 | $2,862 | $73 |
| Long return visit (40+ min) | 18 | $2,388 | $133 |
| New patient complete exam of visual system | 25 | $2,115 | $85 |
| Established patient problem focused exam of visual system | 31 | $1,919 | $45 |
| Established patient complete exam of visual system | 24 | $1,771 | $68 |
| Return visit (30+ min) | 13 | $1,077 | $67 |
2015: 16 services
| Removal of cataract with insertion of prosthetic lens | 73 | $61,438 | $591 |
| Established patient complete exam of visual system | 376 | $40,080 | $105 |
| Established patient problem focused exam of visual system | 239 | $27,333 | $76 |
| New patient complete exam of visual system | 82 | $10,493 | $128 |
| Complex removal of cataract with insertion of prosthetic lens | 13 | $10,228 | $731 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $8,759 | $292 |
| Return visit (30+ min) | 69 | $6,715 | $84 |
| Ultrasound scan to determine eye length and lens power | 72 | $6,566 | $61 |
| Exam of visual field with extended testing | 93 | $5,506 | $57 |
| Laser repair to improve eye fluid flow | 12 | $5,142 | $271 |
| New patient visit (45+ min) | 32 | $3,801 | $119 |
| Established patient complete exam of visual system | 26 | $1,935 | $69 |
| Established patient problem focused exam of visual system | 26 | $1,370 | $43 |
| New patient complete exam of visual system | 11 | $959 | $87 |
| Short return visit (20+ min) | 12 | $865 | $62 |
| Return visit (30+ min) | 11 | $544 | $49 |
2014: 14 services
| Removal of cataract with insertion of prosthetic lens | 59 | $45,907 | $612 |
| Established patient complete exam of visual system | 371 | $39,237 | $105 |
| Established patient problem focused exam of visual system | 242 | $26,481 | $72 |
| Complex removal of cataract with insertion of prosthetic lens | 17 | $15,060 | $717 |
| Removal of recurring cataract in lens capsule using a laser | 33 | $12,164 | $297 |
| New patient complete exam of visual system | 97 | $11,300 | $116 |
| Ultrasound scan to determine eye length and lens power | 65 | $5,777 | $80 |
| Exam of visual field with extended testing | 82 | $4,728 | $55 |
| Short return visit (20+ min) | 54 | $3,686 | $62 |
| Return visit (30+ min) | 32 | $3,007 | $91 |
| New patient visit (45+ min) | 18 | $2,165 | $120 |
| New patient complete exam of visual system | 17 | $1,294 | $76 |
| Established patient problem focused exam of visual system | 20 | $1,087 | $42 |
| Established patient complete exam of visual system | 20 | $898 | $43 |
2013: 14 services
| Removal of cataract with insertion of prosthetic lens | 88 | $70,604 | $593 |
| Established patient complete exam of visual system | 431 | $42,054 | $96 |
| Established patient problem focused exam of visual system | 331 | $38,293 | $68 |
| Removal of recurring cataract in lens capsule using a laser | 40 | $14,359 | $306 |
| New patient complete exam of visual system | 111 | $13,843 | $125 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $8,047 | $732 |
| Ultrasound scan to determine eye length and lens power | 78 | $6,674 | $86 |
| Laser repair to improve eye fluid flow | 14 | $6,331 | $288 |
| Exam of visual field with extended testing | 87 | $5,629 | $63 |
| Long return visit (40+ min) | 24 | $2,862 | $119 |
| Established patient complete exam of visual system | 27 | $1,734 | $56 |
| Established patient problem focused exam of visual system | 23 | $1,630 | $47 |
| Return visit (30+ min) | 17 | $1,611 | $95 |
| Short return visit (20+ min) | 20 | $1,343 | $64 |
Medicaid work
$64,432 in 2024
Medicaid paid $64,432 for 1,607 billed services this clinician did in 2024, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $14,604 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 315 | $12,984 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 216 | $8,171 |
| New patient visit (45+ min) | 56 | $7,615 |
| Short return visit (20+ min) | 111 | $7,014 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 329 | $5,259 |
| Return visit (30+ min) | 60 | $3,019 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 181 | $2,425 |
| DETERMINATION REFRACTIVE STATE | 257 | $1,481 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 29 | $1,060 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 27 | $507 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 14 | $292 |
| 2024 | 1,607 | 12 | 46 | $64,432 |
| 2023 | 1,505 | 10 | 51 | $32,804 |
| 2022 | 1,292 | 9 | 51 | $49,990 |
| 2021 | 1,376 | 12 | 52 | $42,437 |
| 2020 | 982 | 7 | 42 | $32,321 |
| 2019 | 1,458 | 10 | 47 | $67,547 |
| 2018 | 1,234 | 11 | 41 | $45,840 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 338 | $11,815 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 281 | $8,201 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 336 | $4,907 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 65 | $1,459 |
| DETERMINATION REFRACTIVE STATE | 270 | $1,446 |
| Return visit (30+ min) | 27 | $1,182 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 26 | $1,136 |
| New patient visit (45+ min) | 14 | $1,017 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 92 | $872 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 56 | $768 |
2022
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $14,523 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 312 | $10,949 |
| Return visit (30+ min) | 158 | $6,786 |
| New patient visit (45+ min) | 59 | $5,507 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 193 | $5,066 |
| Short return visit (20+ min) | 83 | $2,744 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 158 | $2,163 |
| DETERMINATION REFRACTIVE STATE | 305 | $2,071 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 12 | $181 |
2021
| New patient visit (45+ min) | 147 | $15,397 |
| Return visit (30+ min) | 124 | $7,234 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 167 | $4,549 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 248 | $3,936 |
| DETERMINATION REFRACTIVE STATE | 473 | $3,275 |
| Short return visit (20+ min) | 87 | $3,263 |
| Long return visit (40+ min) | 14 | $1,329 |
| New patient visit (30+ min) | 12 | $1,229 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 39 | $1,148 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 38 | $1,020 |
| Injection, adrenalin, epinephrine, 0.1 mg | 15 | $33 |
| Fentanyl citrate injection | 12 | $26 |
2020
| Return visit (30+ min) | 232 | $10,089 |
| Long return visit (40+ min) | 133 | $7,513 |
| New patient visit (45+ min) | 50 | $5,023 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 117 | $3,776 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 102 | $2,794 |
| DETERMINATION REFRACTIVE STATE | 311 | $2,144 |
| Short return visit (20+ min) | 37 | $981 |
2019
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 29 | $26,015 |
| Return visit (30+ min) | 340 | $12,269 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 233 | $7,711 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 160 | $6,039 |
| Long return visit (40+ min) | 143 | $5,754 |
| New patient visit (45+ min) | 75 | $5,696 |
| DETERMINATION REFRACTIVE STATE | 404 | $2,793 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 36 | $507 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 13 | $474 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 25 | $289 |
2018
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 27 | $9,588 |
| Return visit (30+ min) | 240 | $8,170 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 258 | $7,850 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 198 | $6,562 |
| Long return visit (40+ min) | 100 | $5,764 |
| New patient visit (45+ min) | 27 | $3,023 |
| DETERMINATION REFRACTIVE STATE | 314 | $2,068 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 14 | $979 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 26 | $921 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 17 | $665 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 13 | $249 |
Drugs they prescribed that Part D paid
$172,227
Pharmacies billed $172,227 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,835) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
999 generic and fewer than 11 brand-name prescriptions · $172,227 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 83 | $40,634 | $490 |
| Restasis | 21 | $14,574 | $694 |
| Vyzulta | 14 | $11,277 | $806 |
| Brimonidine Tartrate-Timolol | 26 | $9,946 | $383 |
| Latanoprost | 538 | $9,758 | $18 |
See all 19 drugs
| Lumigan | 83 | $40,634 | $490 |
| Restasis | 21 | $14,574 | $694 |
| Vyzulta | 14 | $11,277 | $806 |
| Brimonidine Tartrate-Timolol | 26 | $9,946 | $383 |
| Latanoprost | 538 | $9,758 | $18 |
| Cyclosporine | 38 | $6,198 | $163 |
| Prednisolone Acetate | 140 | $6,030 | $43 |
| Tobramycin-Dexamethasone | 68 | $4,639 | $68 |
| Azelastine | 195 | $4,344 | $22 |
| Brimonidine | 58 | $3,831 | $66 |
| Travoprost | 21 | $3,711 | $177 |
| Timolol Maleate | 134 | $3,541 | $26 |
| Dorzolamide-Timolol | 179 | $3,013 | $17 |
| Moxifloxacin | 107 | $2,275 | $21 |
| Bimatoprost | 11 | $1,385 | $126 |
| Flurbiprofen | 12 | $772 | $64 |
| Ketorolac Tromethamine | 14 | $394 | $28 |
| Dorzolamide | 13 | $253 | $19 |
| Neomycin-Polymyxin-Dexameth | 16 | $193 | $12 |
Year by year
| 2024 | 1,835 | 457 | 0% (0) | None | $172,227 |
| 2023 | 1,928 | 472 | 0% (0) | None | $250,500 |
| 2022 | 2,339 | 485 | 0% (0) | 47% | $336,698 |
| 2021 | 2,748 | 524 | 0% (0) | 55% | $412,311 |
| 2020 | 2,756 | 531 | 0% (0) | 51% | $422,492 |
| 2019 | 2,761 | 548 | 0% (0) | 53% | $433,689 |
| 2018 | 2,929 | 544 | 0% (0) | 56% | $363,968 |
| 2017 | 3,073 | 549 | 0% (0) | 59% | $382,044 |
| 2016 | 3,181 | 508 | 0% (0) | 58% | $367,558 |
| 2015 | 3,229 | 508 | 0% (0) | 60% | $330,094 |
| 2014 | 2,882 | 482 | 0% (0) | 60% | $247,790 |
| 2013 | 2,876 | 470 | None | 64% | $226,536 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Lumigan | 112 | $59,167 | $528 |
| Xiidra | 24 | $21,499 | $896 |
| Restasis | 25 | $19,935 | $797 |
| Latanoprost | 532 | $17,103 | $32 |
| Cyclosporine | 46 | $16,582 | $360 |
| Brimonidine Tartrate-Timolol | 20 | $11,297 | $565 |
| Alphagan P | 13 | $9,000 | $692 |
| Brinzolamide | 16 | $8,948 | $559 |
| Tobramycin-Dexamethasone | 94 | $7,873 | $84 |
| Prednisolone Acetate | 148 | $7,765 | $52 |
| Rhopressa | 20 | $6,743 | $337 |
| Rocklatan | 11 | $6,430 | $585 |
| Azelastine | 161 | $5,895 | $37 |
| Travoprost | 21 | $5,381 | $256 |
| Moxifloxacin | 141 | $5,269 | $37 |
| Timolol Maleate | 137 | $4,867 | $36 |
| Dorzolamide-Timolol | 164 | $4,290 | $26 |
| Brimonidine | 49 | $1,784 | $36 |
| Olopatadine | 30 | $864 | $29 |
| Dorzolamide | 14 | $433 | $31 |
| Ketorolac Tromethamine | 13 | $365 | $28 |
| Neomycin-Polymyxin-Dexameth | 17 | $278 | $16 |
| Azithromycin | 12 | $98 | $8 |
2022: 27 drugs
| Lumigan | 142 | $75,149 | $529 |
| Xiidra | 37 | $32,833 | $887 |
| Restasis | 35 | $30,773 | $879 |
| Latanoprost | 664 | $21,319 | $32 |
| Combigan | 26 | $15,179 | $584 |
| Alphagan P | 31 | $14,827 | $478 |
| Rhopressa | 35 | $14,192 | $405 |
| Brimonidine Tartrate-Timolol | 27 | $12,922 | $479 |
| Cyclosporine | 34 | $10,803 | $318 |
| Tobramycin-Dexamethasone | 149 | $10,771 | $72 |
| Travoprost | 26 | $9,356 | $360 |
| Dorzolamide-Timolol | 180 | $8,619 | $48 |
| Azelastine | 193 | $8,338 | $43 |
| Restasis Multidose | 13 | $8,294 | $638 |
| Vyzulta | 18 | $7,100 | $394 |
| Timolol Maleate | 145 | $7,073 | $49 |
| Prednisolone Acetate | 132 | $6,521 | $49 |
| Brimonidine | 55 | $5,079 | $92 |
| Moxifloxacin | 113 | $4,138 | $37 |
| Lotemax | 12 | $3,351 | $279 |
| Acyclovir | 35 | $1,808 | $52 |
| Olopatadine | 52 | $1,719 | $33 |
| Dorzolamide | 21 | $1,014 | $48 |
| Flurbiprofen | 12 | $742 | $62 |
| Ketorolac Tromethamine | 15 | $475 | $32 |
| Atropine Sulfate | 11 | $471 | $43 |
| Neomycin-Polymyxin-Dexameth | 23 | $313 | $14 |
2021: 26 drugs
| Lumigan | 157 | $82,834 | $528 |
| Restasis | 65 | $58,574 | $901 |
| Combigan | 78 | $35,114 | $450 |
| Xiidra | 34 | $31,924 | $939 |
| Latanoprost | 687 | $24,362 | $35 |
| Restasis Multidose | 31 | $19,238 | $621 |
| Brimonidine | 77 | $17,088 | $222 |
| Alphagan P | 38 | $16,464 | $433 |
| Rhopressa | 33 | $14,088 | $427 |
| Timolol Maleate | 193 | $11,076 | $57 |
| Tobramycin-Dexamethasone | 130 | $10,972 | $84 |
| Travoprost | 36 | $9,604 | $267 |
| Dorzolamide-Timolol | 184 | $8,862 | $48 |
| Olopatadine | 197 | $8,768 | $45 |
| Tobradex | 29 | $6,967 | $240 |
| Prednisolone Acetate | 203 | $6,844 | $34 |
| Azelastine | 163 | $6,178 | $38 |
| Moxifloxacin | 135 | $5,059 | $37 |
| Bimatoprost | 20 | $3,044 | $152 |
| Lotemax | 11 | $2,906 | $264 |
| Dorzolamide | 38 | $1,975 | $52 |
| Flurbiprofen | 12 | $742 | $62 |
| Neomycin-Polymyxin-Dexameth | 34 | $575 | $17 |
| Acyclovir | 22 | $543 | $25 |
| Carteolol | 11 | $538 | $49 |
| Ketorolac Tromethamine | 14 | $491 | $35 |
2020: 30 drugs
| Lumigan | 174 | $82,640 | $475 |
| Restasis | 68 | $66,498 | $978 |
| Xiidra | 33 | $41,068 | $1,244 |
| Combigan | 94 | $34,009 | $362 |
| Latanoprost | 741 | $24,094 | $33 |
| Alphagan P | 69 | $22,145 | $321 |
| Olopatadine | 342 | $17,596 | $51 |
| Restasis Multidose | 12 | $13,851 | $1,154 |
| Travoprost | 49 | $11,956 | $244 |
| Brimonidine | 62 | $11,391 | $184 |
| Timolol Maleate | 187 | $11,123 | $59 |
| Azopt | 14 | $10,417 | $744 |
| Pazeo | 26 | $8,748 | $336 |
| Tobramycin-Dexamethasone | 92 | $7,202 | $78 |
| Dorzolamide-Timolol | 134 | $6,994 | $52 |
| Prednisolone Acetate | 176 | $6,351 | $36 |
| Tobradex | 23 | $5,435 | $236 |
| Rhopressa | 11 | $5,248 | $477 |
| Moxifloxacin | 107 | $4,789 | $45 |
| Lotemax | 11 | $3,140 | $285 |
| Dorzolamide | 45 | $2,298 | $51 |
| Azelastine | 64 | $2,003 | $31 |
| Bimatoprost | 19 | $1,943 | $102 |
| Flurbiprofen | 13 | $804 | $62 |
| Atropine Sulfate | 13 | $534 | $41 |
| Acyclovir | 17 | $505 | $30 |
| Carteolol | 15 | $438 | $29 |
| Erythromycin | 21 | $348 | $17 |
| Ketorolac Tromethamine | 11 | $346 | $31 |
| Neomycin-Polymyxin-Dexameth | 13 | $209 | $16 |
2019: 23 drugs
| Lumigan | 185 | $93,610 | $506 |
| Restasis | 65 | $69,265 | $1,066 |
| Xiidra | 30 | $36,538 | $1,218 |
| Combigan | 78 | $28,991 | $372 |
| Alphagan P | 67 | $25,890 | $386 |
| Travatan Z | 79 | $23,388 | $296 |
| Latanoprost | 778 | $20,718 | $27 |
| Timolol Maleate | 203 | $19,861 | $98 |
| Pazeo | 76 | $19,013 | $250 |
| Olopatadine | 236 | $12,414 | $53 |
| Tobramycin-Dexamethasone | 126 | $10,759 | $85 |
| Durezol | 43 | $8,439 | $196 |
| Prednisolone Acetate | 212 | $7,851 | $37 |
| Brimonidine | 56 | $7,536 | $135 |
| Dorzolamide-Timolol | 132 | $6,849 | $52 |
| Moxifloxacin | 134 | $5,665 | $42 |
| Tobradex | 14 | $3,201 | $229 |
| Dorzolamide | 51 | $2,450 | $48 |
| Azelastine | 30 | $958 | $32 |
| Erythromycin | 16 | $617 | $39 |
| Atropine Sulfate | 11 | $365 | $33 |
| Acyclovir | 17 | $235 | $14 |
| Neomycin-Polymyxin-Dexameth | 14 | $201 | $14 |
2018: 26 drugs
| Lumigan | 195 | $76,868 | $394 |
| Restasis | 51 | $44,853 | $879 |
| Xiidra | 35 | $35,656 | $1,019 |
| Combigan | 96 | $33,664 | $351 |
| Alphagan P | 73 | $23,414 | $321 |
| Olopatadine | 281 | $19,177 | $68 |
| Travatan Z | 75 | $18,030 | $240 |
| Latanoprost | 840 | $15,125 | $18 |
| Restasis Multidose | 18 | $10,178 | $565 |
| Pazeo | 46 | $9,991 | $217 |
| Timolol Maleate | 216 | $9,838 | $46 |
| Brimonidine | 45 | $8,005 | $178 |
| Tobramycin-Dexamethasone | 110 | $6,598 | $60 |
| Prednisolone Acetate | 236 | $6,596 | $28 |
| Betoptic S | 17 | $5,955 | $350 |
| Moxifloxacin | 134 | $5,714 | $43 |
| Durezol | 32 | $5,659 | $177 |
| Dorzolamide-Timolol | 139 | $4,393 | $32 |
| Tobradex | 11 | $2,457 | $223 |
| Dorzolamide | 53 | $1,179 | $22 |
| Azelastine | 39 | $905 | $23 |
| Atropine Sulfate | 19 | $790 | $42 |
| Neomycin-Polymyxin-Dexameth | 27 | $331 | $12 |
| Acyclovir | 19 | $301 | $16 |
| Erythromycin | 17 | $264 | $16 |
| Ciprofloxacin | 21 | $159 | $8 |
2017: 28 drugs
| Restasis | 116 | $75,994 | $655 |
| Lumigan | 190 | $49,324 | $260 |
| Pataday | 141 | $38,580 | $274 |
| Travatan Z | 122 | $28,232 | $231 |
| Alphagan P | 97 | $27,530 | $284 |
| Durezol | 157 | $25,592 | $163 |
| Latanoprost | 870 | $14,363 | $17 |
| Olopatadine | 144 | $13,285 | $92 |
| Vigamox | 77 | $12,777 | $166 |
| Xiidra | 21 | $12,042 | $573 |
| Brimonidine | 43 | $9,279 | $216 |
| Timolol Maleate | 227 | $9,038 | $40 |
| Pazeo | 41 | $7,997 | $195 |
| Combigan | 32 | $7,925 | $248 |
| Betoptic S | 20 | $7,291 | $365 |
| Tobramycin-Dexamethasone | 104 | $7,043 | $68 |
| Dorzolamide-Timolol | 237 | $6,301 | $27 |
| Betimol | 14 | $2,833 | $202 |
| Prednisolone Acetate | 86 | $2,757 | $32 |
| Moxifloxacin | 40 | $2,736 | $68 |
| Tobradex | 13 | $2,730 | $210 |
| Azelastine | 35 | $1,495 | $43 |
| Dorzolamide | 49 | $1,294 | $26 |
| Atropine Sulfate | 18 | $783 | $44 |
| Epinastine | 15 | $742 | $49 |
| Erythromycin | 15 | $244 | $16 |
| Neomycin-Polymyxin-Dexameth | 19 | $229 | $12 |
| Ciprofloxacin | 31 | $228 | $7 |
2016: 29 drugs
| Restasis | 140 | $71,301 | $509 |
| Pataday | 276 | $69,648 | $252 |
| Travatan Z | 167 | $32,675 | $196 |
| Lumigan | 162 | $31,696 | $196 |
| Alphagan P | 76 | $19,481 | $256 |
| Durezol | 123 | $19,242 | $156 |
| Vigamox | 93 | $17,318 | $186 |
| Latanoprost | 920 | $14,309 | $16 |
| Tobramycin-Dexamethasone | 141 | $11,886 | $84 |
| Timolol Maleate | 195 | $9,333 | $48 |
| Combigan | 47 | $8,901 | $189 |
| Olopatadine | 79 | $8,168 | $103 |
| Dorzolamide-Timolol | 307 | $7,827 | $25 |
| Patanol | 25 | $6,279 | $251 |
| Betoptic S | 20 | $6,211 | $311 |
| Azopt | 16 | $5,411 | $338 |
| Brimonidine | 37 | $5,271 | $142 |
| Pazeo | 14 | $2,921 | $209 |
| Prednisolone Acetate | 65 | $2,693 | $41 |
| Tobradex | 11 | $2,183 | $198 |
| Azelastine | 21 | $1,103 | $53 |
| Dorzolamide | 55 | $1,096 | $20 |
| Epinastine | 16 | $797 | $50 |
| Acyclovir | 18 | $730 | $41 |
| Atropine Sulfate | 15 | $702 | $47 |
| Neomycin-Polymyxin-Dexameth | 28 | $479 | $17 |
| Erythromycin | 14 | $282 | $20 |
| Ciprofloxacin | 18 | $147 | $8 |
| Flurbiprofen | 12 | $128 | $11 |
2015: 27 drugs
| Pataday | 310 | $71,042 | $229 |
| Restasis | 110 | $43,322 | $394 |
| Travatan Z | 162 | $26,158 | $161 |
| Patanol | 102 | $25,063 | $246 |
| Alphagan P | 81 | $18,030 | $223 |
| Vigamox | 123 | $17,423 | $142 |
| Lumigan | 95 | $16,492 | $174 |
| Latanoprost | 932 | $15,846 | $17 |
| Durezol | 102 | $15,651 | $153 |
| Tobramycin-Dexamethasone | 104 | $10,010 | $96 |
| Betoptic S | 33 | $9,172 | $278 |
| Timolol Maleate | 209 | $8,968 | $43 |
| Azopt | 20 | $7,348 | $367 |
| Dorzolamide-Timolol | 298 | $7,347 | $25 |
| Brimonidine | 56 | $7,260 | $130 |
| Prednisolone Acetate | 139 | $4,471 | $32 |
| Combigan | 30 | $4,347 | $145 |
| Lotemax | 12 | $3,874 | $323 |
| Betimol | 14 | $3,800 | $271 |
| Tobradex | 17 | $3,282 | $193 |
| Dorzolamide | 74 | $1,456 | $20 |
| Epinastine | 13 | $967 | $74 |
| Acyclovir | 17 | $525 | $31 |
| Atropine Sulfate | 18 | $418 | $23 |
| Neomycin-Polymyxin-Dexameth | 25 | $369 | $15 |
| Erythromycin | 15 | $366 | $24 |
| Ciprofloxacin | 14 | $153 | $11 |
2014: 27 drugs
| Pataday | 242 | $47,643 | $197 |
| Travatan Z | 199 | $30,369 | $153 |
| Restasis | 75 | $25,806 | $344 |
| Lumigan | 93 | $15,002 | $161 |
| Patanol | 88 | $14,405 | $164 |
| Alphagan P | 75 | $14,287 | $190 |
| Vigamox | 108 | $12,242 | $113 |
| Latanoprost | 770 | $12,193 | $16 |
| Brimonidine | 48 | $9,332 | $194 |
| Durezol | 70 | $8,918 | $127 |
| Dorzolamide-Timolol | 242 | $8,526 | $35 |
| Tobramycin-Dexamethasone | 85 | $7,914 | $93 |
| Timolol Maleate | 260 | $7,447 | $29 |
| Betoptic S | 32 | $6,963 | $218 |
| Azopt | 24 | $5,310 | $221 |
| Betimol | 22 | $3,666 | $167 |
| Prednisolone Acetate | 164 | $3,079 | $19 |
| Lotemax | 14 | $2,856 | $204 |
| Combigan | 20 | $2,390 | $120 |
| Dorzolamide | 60 | $1,621 | $27 |
| Epinastine | 14 | $941 | $67 |
| Levobunolol | 16 | $651 | $41 |
| Acyclovir | 17 | $361 | $21 |
| Neomycin-Polymyxin-Dexameth | 27 | $298 | $11 |
| Atropine Sulfate | 19 | $264 | $14 |
| Flurbiprofen | 11 | $144 | $13 |
| Ciprofloxacin | 16 | $123 | $8 |
2013: 24 drugs
| Pataday | 222 | $38,519 | $174 |
| Travatan Z | 241 | $34,115 | $142 |
| Patanol | 125 | $17,335 | $139 |
| Restasis | 46 | $14,557 | $316 |
| Alphagan P | 69 | $11,854 | $172 |
| Latanoprost | 711 | $11,645 | $16 |
| Vigamox | 112 | $11,509 | $103 |
| Lumigan | 75 | $10,424 | $139 |
| Tobramycin-Dexamethasone | 99 | $9,513 | $96 |
| Dorzolamide-Timolol | 260 | $9,512 | $37 |
| Brimonidine | 66 | $9,386 | $142 |
| Betoptic S | 39 | $8,261 | $212 |
| Durezol | 63 | $7,003 | $111 |
| Azopt | 31 | $5,753 | $186 |
| Betimol | 48 | $4,929 | $103 |
| Timolol Maleate | 226 | $4,387 | $19 |
| Combigan | 27 | $3,059 | $113 |
| Prednisolone Acetate | 186 | $2,413 | $13 |
| Tobradex | 14 | $2,074 | $148 |
| Dorzolamide | 50 | $1,597 | $32 |
| Epinastine | 14 | $1,054 | $75 |
| Levobunolol | 15 | $798 | $53 |
| Neomycin-Polymyxin-Dexameth | 41 | $539 | $13 |
| Acyclovir | 12 | $284 | $24 |
Money from drug and device companies
$451 in 2025
| 2025 | 10 | 18 | None | $451 |
| 2024 | 6 | 11 | None | $280 |
| 2023 | 4 | 4 | None | $76 |
| 2022 | 4 | 5 | None | $102 |
| 2021 | 1 | 1 | None | $18 |
| 2020 | 3 | 4 | None | $76 |
| 2019 | 2 | 6 | None | $100 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Xiidra | $101 | 5 payments
|
| Alcon Vision | Rocklatan | $63 | 2 payments
|
| Amgen | Tepezza | $53 | 2 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $48 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $46 | 2 payments
|
| Harrow Eye | Vevye | $45 | 1 payment
|
See all 18 published payments
| Abbvie | Meals · 2025-12-23 | Lumigan | $24 |
| Alcon Vision | Meals · 2025-12-02 | Rocklatan | $29 |
| Bausch & Lomb Americas | Meals · 2025-12-02 | Envista Envy Iol | $15 |
| Tarsus Pharmaceuticals | Meals · 2025-11-20 | Xdemvy | $25 |
| Thea Pharma | Meals · 2025-10-21 | Iyuzeh | $19 |
| Oyster Point Pharma | Meals · 2025-10-15 | Tyrvaya | $21 |
| Bausch & Lomb Americas | Meals · 2025-10-05 | Vyzulta | $24 |
| Alcon Vision | Meals · 2025-09-16 | Rocklatan | $34 |
| Amgen | Meals · 2025-09-10 | Tepezza | $27 |
| Oyster Point Pharma | Meals · 2025-08-19 | Tyrvaya | $25 |
| Dompe US | Meals · 2025-06-11 | Oxervate | $20 |
| Harrow Eye | Meals · 2025-05-20 | Vevye | $45 |
| Bausch & Lomb Americas | Meals · 2025-05-14 | Miebo | $20 |
| Bausch & Lomb Americas | Meals · 2025-03-13 | Xiidra | $20 |
| Amgen | Meals · 2025-03-04 | Tepezza | $26 |
| Tarsus Pharmaceuticals | Meals · 2025-02-19 | Xdemvy | $22 |
| Astellas Pharma US | Meals · 2025-01-07 | Izervay | $32 |
| Bausch & Lomb Americas | Meals · 2025-01-06 | Xiidra | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $280
| Oyster Point Pharma | Tyrvaya | $64 | 2 payments
|
| Alcon Vision | Rocklatan | $62 | 3 payments
|
| Amgen | Tepezza | $58 | 2 payments
|
| Bausch & Lomb Americas | Vyzulta | $44 | 2 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $27 | 1 payment
|
| Abbvie | Lumigan | $26 | 1 payment
|
2023: $76
| Sight Sciences | Tearcare System | $24 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $18 | 1 payment
|
| Thea Pharma | None | $18 | 1 payment
|
| RxSight | Rxsight Contact Lens | $16 | 1 payment
|
2022: $102
| Bausch & Lomb Americas | Vyzulta | $38 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $25 | 1 payment
|
| Alcon Vision | Rocklatan | $23 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $16 | 1 payment
|
2021: $18
| Sun Pharmaceutical Industries | Cequa | $18 | 1 payment
|
2020: $76
| Aerie Pharmaceuticals | Rocklatan | $35 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $23 | 1 payment
|
| Eyevance Pharmaceuticals | Flarex | $18 | 1 payment
|
2019: $100
| Allergan | Lumigan | $77 | 5 payments
|
| Sun Pharmaceutical Industries | Cequa | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1013916733
- Licence
- CA G62652California G62652: Current · expires 2028-02-29
- Trained
- Tulane University School of Medicine, 1983 · 43 years ago
- Group
- Farallon Eye Physicians Corp · County of San Mateo
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA GR0066060
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1800 Sullivan Ave Rm 410, Daly City, CA, 94015
- NPI first listed
- 2005-07-14
- NPI last updated
- 2016-01-31
This is when the NPI record was last certified, not a medical board exam.